Immatics N.V. (IMTX) reporting calendar
Immatics N.V. files periodic reports with the SEC as IMTX on Nasdaq. Atlas tracks 7 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 11 Aug 2026 – 1 Nov 2026
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 5 Mar 2026
- Reports on record
- 7
How this window is derived. Derived from this issuer's own filing history: 2 periods at a median 183-day cadence, filed a median 81 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open IMTX market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 5 Mar 2026 | 64 days | 0001193125-26-092529 |
| 20-F | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0000950170-25-045724 |
| 20-F | 31 Dec 2023 | 21 Mar 2024 | 81 days | 0001193125-24-073296 |
| 20-F | 31 Dec 2022 | 22 Mar 2023 | 81 days | 0001193125-23-076227 |
| 20-F | 31 Dec 2021 | 23 Mar 2022 | 82 days | 0001193125-22-082242 |
| 20-F | 31 Dec 2020 | 30 Mar 2021 | 89 days | 0001193125-21-099162 |
| 20-F | 1 Jul 2020 | 8 Jul 2020 | 7 days | 0001193125-20-189264 |
Source: SEC EDGAR company submissions for CIK 0001809196. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.